Literature DB >> 16557893

Susceptibility of Staphylococci to Minocycline In Vitro: Identification of Group III Bacteriophage Types by Characteristic Inhibition of Growth.

J P Phair1, J Carleton.   

Abstract

Minocycline in concentrations of 1.0 mug per ml or less inhibited growth of 50 staphylococcal isolates which were tested by the broth dilution method. All strains were resistant to penicillin and tetracycline, and 34% were resistant to lincomycin. Minocycline discs identified two populations of minocycline-susceptible strains. The first group with small zones of inhibition surrounding the disc had multiple resistance and all were lysed by group III phage (84/85). The organisms with larger diameter of zones of inhibition were less frequently resistant to the antibiotics tested, and only 7.4% of these organisms were lysed by the 84/85 phage.

Entities:  

Year:  1970        PMID: 16557893      PMCID: PMC416066          DOI: 10.1128/iai.2.5.669-671.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  SIMPLE METHOD FOR PHAGE TYPING OF STAPHYLOCOCCI.

Authors:  H J SIMON; S UNDSETH
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

2.  Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results.

Authors:  A W BAUER; D M PERRY; W M KIRBY
Journal:  AMA Arch Intern Med       Date:  1959-08

3.  The techniques and interpretation of phage typing of staphylococci.

Authors:  J E BLAIR; M CARR
Journal:  J Lab Clin Med       Date:  1960-04

4.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

5.  Computer-generated plots of results of antimicrobial-susceptibility tests.

Authors:  T F O'Brien; R L Kent; A A Medeiros
Journal:  JAMA       Date:  1969-10-06       Impact factor: 56.272

6.  Clinical evaluation of minocycline.

Authors:  A R Frisk; G Tunevall
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

7.  Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia.

Authors:  O Jessen; K Rosendal; P Bülow; V Faber; K R Eriksen
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

  7 in total
  6 in total

1.  Evaluation of the efficacy of minocycline therapy for staphylococcal soft-tissue infection.

Authors:  J P Phair; R E Hartman; J Carleton
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

2.  Minocycline resistance in Staphylococcus aureus: effect on phage susceptibility.

Authors:  S Schaefler; W Francois; C L Ruby
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

3.  Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

5.  Minocycline sensitivity related to the phage type of multiply resistant staphylococci.

Authors:  G Rich; J Davidson
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

6.  Uptake of minocycline and tetracycline by tetracycline-susceptible and -resistant bacteria.

Authors:  N A Kuck; M Forbes
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.